Document Type : Full Research Paper


1 Department of Biophysics & Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran - Research Center for Biomedical Technologies and Robotics (RCBTR), Tehran University of Medical Sciences, Tehran, Iran

2 Department of Radiology, Sari School of Allied Medical Sciences, Mazandaran University of Medical Sciences, Sari, Iran

3 Associate Professor, Department of Biophysics & Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran - Research Center for Biomedical Technologies and Robotics (RCBTR), Tehran University of Medical Sciences, Tehran, Iran


In recent decades, due to the increased prevalence of diabetes and its chronic complications, glucose measurement, modeling of glucose-insulin system and glucose control have been especially important. Since the type I diabetes does not secrete insulin, cells do not absorb glucose, and thus the blood glucose level increase. In order to control your blood sugar, insulin should besubcutaneously injected into the body under complex, controlled conditions. If the level of insulin increases beyond the natural physiological range, there is a risk of death. There are various treatments for diabetes, the main treatment of which is insulin therapy. Monitoring the patient's blood sugar level continuously during the day and night is a very good treatment strategy, since it controls the patient's blood sugar level in a safe area with the lowest amount of insulin injected at the required times. This mechanism avoid the hyperglycemia (blood glucose levels greater than 120 mg/dl) and hypoglycemia (blood sugar less than 65 mg / dl). To achieve this goal, a two delay model has been developed to model blood glucose levels continuously during time. Some of the parameters of this model are estimated using the genetic algorithm to achieve the best fitness between the dynamics of the model with the experimental data obtained in this study. As a result, the developed model of this study can dynamically obtain blood glucose continuously during time, consequently it can predicts the insulin dynamics required to be injected into the patient to control the amount of blood glucose in the normal range. Therefore this controlling system is capable of preventing hypoglycemia and hyperglycemia.


Main Subjects

[1]     Association AD. Economic costs of diabetes in the US in 2007. Diabetes care 2008;31:596-615.
[3]     Guyton AC, Hall J. Textbook of Medical Physiology Philadelphia: Saunders; 1986. NOTE: Additional information on Movement Strategies for Balance, Sensory Organization, Age-related changes in balance and CTSIB test result interpretation can be found in the Appendix C 1976.
[4]     Stern MP. Diabetes and cardiovascular disease: the “common soil” hypothesis. Diabetes 1995;44:369-74.
[5]     Surwit RS, Feinglos MN. The effects of relaxation on glucose tolerance in non-insulin-dependent diabetes. Diabetes Care 1983;6:176-9.
[6]     Deiss D, Bolinder J, Riveline J-P, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes care 2006;29:2730-2.
[7]     Ackerman E, Gatewood LC, Rosevear JW, Molnar GD. Model studies of blood-glucose regulation. The bulletin of mathematical biophysics 1965;27:21-37.
[8]     Bergman RN, Cobelli C. Minimal modeling, partition analysis, and the estimation of insulin sensitivity.  Federation proceedings1980. p. 110.
[9]     Drozdov A, Khanina H. A model for ultradian oscillations of insulin and glucose. Mathematical and computer modelling 1995;22:23-38.
[10] Panunzi S, Palumbo P, De Gaetano A. A discrete single delay model for the intra-venous glucose tolerance test. Theoretical Biology and Medical Modelling 2007;4:35.
[11] Sorensen JT, Colton CK, Hillman RS, Soeldner JS. Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies. Diabetes Care 1982;5:148-57.
[12] Eren-Oruklu M, Cinar A, Quinn L, Smith D. Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes. Journal of process control 2009;19:1333-46.
[13]  نفیسی و,، گلپایگانی س.م.، سیستم تزریق هوشمند انسولین در بیماران دیابتی با استفاده از شبکه عصبی و الگوریتم فازی. مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، 2003;5:203-10.
[14] Li J, Kuang Y, Mason CC. Modeling the glucose–insulin regulatory system and ultradian insulin secretory oscillations with two explicit time delays. Journal of Theoretical Biology 2006;242:722-35.
[15] Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes care 1987;10:622-8.
[16] Hall JE. Pocket Companion to Guyton & Hall Textbook of Medical Physiology E-Book: Elsevier Health Sciences; 2015.
[17] Friis-Jensen E. Modeling and simulation of glucose-insulin metabolism.  Congress Lyngby2007.
[18] De Gaetano A, Arino O. Mathematical modelling of the intravenous glucose tolerance test. Journal of mathematical biology 2000;40:136-68.
[19] Netter F, Colacino S. Atlas of human anatomy: Ciba-Geigy Summit. NJ; 1989.
[20] Salzsieder E, Albrecht G, Fischer U, Freyse E-J. Kinetic modeling of the glucoregulatory system to improve insulin therapy. IEEE Transactions on Biomedical Engineering 1985:846-55.
[21] Mahata A, Mondal SP, Alam S, Roy B. Mathematical model of glucose-insulin regulatory system on diabetes mellitus in fuzzy and crisp environment. Ecological Genetics and Genomics 2017;2:25-34.
[22] Sandhya S, Kumar D. Mathematical model for glucose-insulin regulatory system of diabetes mellitus. Advances in Applied Mathematical Biosciences 2011;2:39-46.
[23] Bede B, Gal SG. Generalizations of the differentiability of fuzzy-number-valued functions with applications to fuzzy differential equations. Fuzzy sets and systems 2005;151:581-99.